Posts Tagged: Prostate Cancer

Brachytherapy for Prostate Cancer

Brachytherapy has been proven as a highly effective prostate cancer treatment. This outpatient procedure, which is usually finished in about an hour, uses radiation in the form of tiny “seeds” that are carefully injected via a needle-stick into the prostate, near the tumor. There is no cutting or suturing, and patients may return to 100%… Read more »

To PSA or not to PSA: That Is the Thorny Question

Fewer men are undergoing prostate-specific antigen (PSA) evaluations since the United States Preventive Services Task Force (USPSTF) announced its controversial recommendation not to undergo the PSA test. This will lead to lower diagnosis and subsequent treatment rates for prostate cancer. According to the results of this task force, a PSA test would never be performed,… Read more »

CyberKnife, the Lifestyle-Friendly Prostate Cancer Treatment

Patients with localized prostate cancer have a new choice for treatment. Called CyberKnife stereotactic body radiotherapy (SBRT), this option is based on radiosurgery. Radiosurgery is a noninvasive technique that targets tumors with high doses of radiation. CyberKnife SBRT kills prostate cancer cells while it minimizes exposure to radiation of nearby, healthy tissue like the bladder… Read more »

7 Things Men Can Expect During a Urologist Office Visit

If you’re a man who’s hasn’t made his first urologist office visit, you may wonder what to expect. First, it’s helpful to understand who urologists are. They are physicians who specialize in the genitourinary tract—the kidneys, urinary bladder, adrenal glands, urethra and male reproductive organs—and male fertility. Urologists are also trained in the surgical and… Read more »

Radical Prostatectomy or Observation for Localized Prostate Cancer?

In a landmark study published in the New England Journal of Medicine, Dr. Wilt and the PIVOT Study Group reported the results of the first randomized controlled study of radical prostatectomy versus observation for the treatment of prostate cancer in the modern PSA (prostate cancer screening) era. The study randomized 731 men with clinically localized… Read more »

Buffett’s Prostate Cancer Is Not a Death Knell

Warren Buffett has announced to shareholders that he has the most common cancer in men, Stage 1 prostate cancer. The information he released is insufficient to determine prognosis let alone what treatment is needed, if any. However, statistics are generally on Mr. Buttett’s side. Autopsy studies show that most men will eventually present with prostate… Read more »

Controversy Persists About Prostate Cancer Screening

In 2009, the publication of the results of two large screening studies ignited the controversy over prostate-specific antigen (PSA) testing and prostate cancer screening. Now, both studies have been updated and debate continues. This month, the New England Journal of Medicine published an update of the European Randomized Study of Screening for Prostate Cancer (ERSPC)… Read more »